UA31325A - METHOD OF TREATMENT OF OSTEOPENIC SYNDROME IN CHILDREN AND ADOLESCENTS WITH SYSTEMIC RED WOLF - Google Patents

METHOD OF TREATMENT OF OSTEOPENIC SYNDROME IN CHILDREN AND ADOLESCENTS WITH SYSTEMIC RED WOLF

Info

Publication number
UA31325A
UA31325A UA98084290A UA98084290A UA31325A UA 31325 A UA31325 A UA 31325A UA 98084290 A UA98084290 A UA 98084290A UA 98084290 A UA98084290 A UA 98084290A UA 31325 A UA31325 A UA 31325A
Authority
UA
Ukraine
Prior art keywords
treatment
adolescents
children
day
per
Prior art date
Application number
UA98084290A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Наталя Станіславівна Шевченко
Галина Микитівна Костюріна
Галина Никитовна Костюрина
Original Assignee
Український Науково-Дослідний Інститут Охорони Здоров'Я Дітей І Підлітків
Украинский Научно-Исследовательский Институт Охраны Здоровья Детей И Подростков
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Український Науково-Дослідний Інститут Охорони Здоров'Я Дітей І Підлітків, Украинский Научно-Исследовательский Институт Охраны Здоровья Детей И Подростков filed Critical Український Науково-Дослідний Інститут Охорони Здоров'Я Дітей І Підлітків
Priority to UA98084290A priority Critical patent/UA31325A/en
Publication of UA31325A publication Critical patent/UA31325A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to medicine, namely to rheumatology. The essence of a method for treatment osteopenic syndrome in children and adolescents with systemic lupus erythematosus consists in that on the background of the basic pathogenetic treatment with glucocorticoids the OSTEOKHIN antiosteoporous preparation is prescribed in dozes: at body weight up to 30 kg – per 100 mg 3 times a day, up to 60 kg – per 200 mg 2 times a day, more than 60 kg – per 200 mg 3 times a day. The are prescribed after the completion of therapy by glucocorticoids in suppressing doze during two-three months in combination with preparations of calcium. If necessary repeated course of treatment is carried out under such scheme in 6-12 months.
UA98084290A 1998-08-06 1998-08-06 METHOD OF TREATMENT OF OSTEOPENIC SYNDROME IN CHILDREN AND ADOLESCENTS WITH SYSTEMIC RED WOLF UA31325A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA98084290A UA31325A (en) 1998-08-06 1998-08-06 METHOD OF TREATMENT OF OSTEOPENIC SYNDROME IN CHILDREN AND ADOLESCENTS WITH SYSTEMIC RED WOLF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA98084290A UA31325A (en) 1998-08-06 1998-08-06 METHOD OF TREATMENT OF OSTEOPENIC SYNDROME IN CHILDREN AND ADOLESCENTS WITH SYSTEMIC RED WOLF

Publications (1)

Publication Number Publication Date
UA31325A true UA31325A (en) 2000-12-15

Family

ID=74283344

Family Applications (1)

Application Number Title Priority Date Filing Date
UA98084290A UA31325A (en) 1998-08-06 1998-08-06 METHOD OF TREATMENT OF OSTEOPENIC SYNDROME IN CHILDREN AND ADOLESCENTS WITH SYSTEMIC RED WOLF

Country Status (1)

Country Link
UA (1) UA31325A (en)

Similar Documents

Publication Publication Date Title
ATE281840T1 (en) TREATMENT OF DIARRHEA
CA2314326A1 (en) Transdermal therapeutic device and method with capsaicin and capsaicin analogs
RO116342B1 (en) Oral liquid pharmaceutical composition
PT914114E (en) METHODS OF TREATMENT OF TYPE I HYPERSENSITIVITY USING MONOPHOSPHALYLIPID A
AU6414994A (en) Composition and method for reducing toxicity of biologically-active factors
NZ516349A (en) Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease
GR3031263T3 (en) Use of L-deprenyl for retarding age dependent deterioration of the immune system function in mammals
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
ES2002432A6 (en) Improvements relating to hydraulic binders.
ID27765A (en) GEL PLESTER THAT CONTAINS STEROID AND THE PROCESS OF MAKING IT
EP1093816A3 (en) Use of ST1435 in hormonal therapy by transdermal application
MD990258A (en) Method of treatment of the acute viral hepatitis B
UA31325A (en) METHOD OF TREATMENT OF OSTEOPENIC SYNDROME IN CHILDREN AND ADOLESCENTS WITH SYSTEMIC RED WOLF
EP0642333A4 (en) Method and composition for the treatment of disorders involving immunological dysfunction.
WO1999056767A3 (en) Method for treating cytokine mediated hepatic injury
Kushaba-Rugaaju THE REGULATION OF UTERINE ADENYLATE CYCLASE AND FREE CALCIUM ION BY OVARIAN STEROID HORMONES.
KR880009652A (en) Therapeutic rheumatoid arthritis using 3-5-dichloro methotrexate and compositions useful therein
RU93029234A (en) METHOD FOR COMPLETING COLONSTRAL IMMUNITY IN NEWBORN CALVES
UA49213A (en) Method for treating premature menarche
RU93042731A (en) METHOD FOR TREATING POSTNATAL HYPOTROPHY
Yokoyama et al. Tryptophan Pyrrolase Activity in Rats Subjected to Electic Convulsions
MD344G2 (en) Method of prophylaxis and treatment of exogenous obesity
UA7076A (en) Method for treating nephroitic form of primary glomerulonephritis in children
IE780730L (en) Veterinary composition
UA23932A (en) Method for simulating colitis